U.S. Capital Markets Stock News

NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

ARK Invest Backs Robinhood As Singapore Approval Shifts Growth Focus

ARK Invest purchased over US$39 million of Robinhood Markets (NasdaqGS:HOOD) shares shortly after the company reported a Q1 earnings miss and a substantial decline in crypto revenue. Robinhood received in principle regulatory approval to launch securities brokerage services in Singapore, advancing its international expansion plans. These developments arrive as investor attention is focused on Robinhood's business mix and long term direction beyond near term trading and crypto...
NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

A Look At Fluence Energy (FLNC) Valuation After Analyst Downgrades And Battery Oversupply Concerns

Fluence Energy (FLNC) is back in focus after UBS downgraded the stock to Sell, citing rising competition and potential battery oversupply. Citi also flagged a more cautious near term outlook for alternative energy equipment. See our latest analysis for Fluence Energy. The recent analyst downgrades and concerns about battery oversupply have come after a sharp reset in sentiment, with a 90 day share price return of 60.42% decline and a year to date share price return of 47.07% decline, even...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

How Moderna (MRNA) Is Recasting Its Vaccine Platform After EU Approval of Its First Combo Shot

In April 2026, the European Commission granted marketing authorization for Moderna’s mCOMBRIAX (mRNA-1083), the first approved mRNA combination influenza and COVID-19 vaccine for adults aged 50 and over across the EU, Iceland, Liechtenstein, and Norway. Around the same time, the Global Virus Network publicly backed Moderna’s progress on its mRNA H5N1 avian influenza vaccine, underscoring how the company’s mRNA platform is being applied to multiple high-impact respiratory threats beyond...
NYSE:NIQ
NYSE:NIQMedia

Is NIQ Global Intelligence (NIQ) Offering An Opportunity After This Year’s 30% Share Price Slide

This article considers whether NIQ Global Intelligence, at around US$10.93, offers value or simply appears cheap on the surface by examining what the current price might really imply. The share price has eased back recently, with a 7‑day return of a 2.6% decline, a 30‑day return of a 3.9% decline, and a year‑to‑date return of a 30.7% decline. Recent coverage has focused on the stock's weaker near‑term returns and what they might signal about investor expectations, which helps explain why...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Viavi Solutions (VIAV) Q3 Profit Challenges Bearish Narratives On Persistent Losses

Viavi Solutions (VIAV) just posted Q3 2026 results with revenue of US$406.8 million and basic EPS of US$0.03, while on a trailing twelve month basis revenue stands at US$1.4 billion with a basic EPS loss of US$0.24. Over recent quarters, the company has seen revenue move from US$270.8 million in Q2 2025 to US$406.8 million in Q3 2026, alongside basic EPS shifting from US$0.04 in Q2 2025 to US$0.03 in the latest quarter and swinging between profits and losses in the periods in between. This...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Arch Capital Group (ACGL) Valuation Check After Recent Short Term Share Price Swings

Short term swings and longer term returns Arch Capital Group (ACGL) has seen mixed recent share price moves, with a 1 day return of 1.9%, a 7 day decline of 3.7%, and modestly negative performance over the month and past 3 months. Even with this recent softness, the stock shows a 1 year total return of 5.3% and stronger cumulative gains over 3 and 5 years, which can help you compare recent volatility with longer holding periods. See our latest analysis for Arch Capital Group. Recent trading...
NYSE:ATI
NYSE:ATIAerospace & Defense

ATI (ATI) Net Margin Of 8.8% Tests Bullish Profit Expansion Narrative

ATI (ATI) has opened Q1 2026 earnings season with Q4 2025 revenue of US$1.2 billion and basic EPS of US$0.71, setting the stage against a current share price of US$155.46 as investors focus on how these results fit into the company’s recent earnings trajectory. Over the past year, quarterly revenue has ranged from US$1.1 billion to US$1.2 billion, while basic EPS has moved between US$0.64 and US$0.80. This provides a clear view of how the top and bottom line have tracked together across...
NYSE:AEM
NYSE:AEMMetals and Mining

Agnico Eagle Mines (AEM) Is Down 5.4% After Earnings Beat, Dividend Hike, and Finland Acquisitions

Agnico Eagle Mines Limited recently reported first-quarter 2026 results, with net income rising to US$1.70 billion from US$814.73 million a year earlier and basic earnings per share from continuing operations increasing to US$3.39 from US$1.62. The company paired these stronger margins and earnings with a US$0.45 per-share dividend, share repurchases, and new acquisitions in Finland that consolidate control over the Central Lapland Greenstone Belt and the Ikkari gold project. We’ll now...
NasdaqGS:INBX
NasdaqGS:INBXBiotechs

A Look At Inhibrx Biosciences (INBX) Valuation After New Ozekibart Data And BLA Submission

Why the latest ozekibart update matters for Inhibrx Biosciences investors Inhibrx Biosciences (INBX) has drawn fresh attention after releasing updated interim data for ozekibart in colorectal cancer and submitting a Biologics License Application for the drug in conventional chondrosarcoma. See our latest analysis for Inhibrx Biosciences. The latest ozekibart updates arrive against a backdrop of intense trading interest, with the share price at US$129.21 and a 30 day share price return of...
NYSE:AWR
NYSE:AWRWater Utilities

A Look At American States Water (AWR) Valuation After Recent Share Price Pullback

Key recent performance for American States Water American States Water (AWR) has been relatively steady recently, with the stock showing a small move over the past month and a modest positive return in the past 3 months, despite a negative 1 year total return. See our latest analysis for American States Water. The recent pullback, with a 1 day share price return of a 3.31% decline and a 7 day share price return of a 6.82% decline from US$75.29, contrasts with a year to date share price gain...
NYSE:RPM
NYSE:RPMChemicals

A Look At RPM International (RPM) Valuation As Mixed Returns Contrast With Undervalued Narrative

RPM International: recent performance snapshot RPM International (RPM) shares recently closed at US$101.89, with mixed return patterns across different holding periods that may catch your eye if you track both shorter swings and multi year performance. See our latest analysis for RPM International. Recent price action has been choppy, with a 1 day share price return of 1.19% and a 30 day share price return of 2.50% set against a 1 year total shareholder return of a 3.40% decline. This points...
NYSE:FCN
NYSE:FCNProfessional Services

FTI Consulting (FCN) Margin Slippage Revives Bearish Narrative Ahead Of Q1 2026 Earnings

FTI Consulting (FCN) has opened 2026 with investors focused on how its latest quarter measures up to a steady run of results that most recently saw Q4 2025 revenue of US$990.7 million and basic EPS of US$1.80, supported by trailing 12 month basic EPS of US$8.33 on revenue of about US$3.8 billion. Over the past few quarters the company has seen revenue move from US$894.9 million in Q4 2024 to US$898.3 million in Q1 2025 and then to US$990.7 million in Q4 2025, while basic EPS has ranged from...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

Fortinet (FTNT) Valuation Check As Shares Sit Below Intrinsic Value And Show Mixed Return Signals

Key recent performance and context Fortinet (FTNT) has drawn fresh investor attention after recent trading, with the share price closing at US$84.31 and showing mixed return patterns over the past year and multi year periods. Shorter term returns are positive, with gains over the past week and month, and a modest rise over the past 3 months. Year to date, the stock is also in positive territory, in contrast with a 1 year total return decline. Over longer horizons, the 3 year and 5 year total...
NYSE:CE
NYSE:CEChemicals

Is It Too Late To Consider Celanese (CE) After Its Strong Year To Date Rally

Investors may be wondering if Celanese is still attractively priced after its recent run, or if most of the value story is already reflected in the share price. The stock last closed at US$67.76, with returns of 3.9% over the past week, 3.0% over the past month, 60.7% year to date, and 49.6% over the past year, set against longer term returns of negative 30.6% over three years and negative 56.5% over five years. Recent coverage has focused on Celanese's position in the chemicals sector and...
NYSE:VIK
NYSE:VIKHospitality

Viking Holdings TIME100 Honor And Nile Expansion Shape Growth Story

Viking Holdings (NYSE:VIK) has been named to TIME's 2026 TIME100 Most Influential Companies list as a "Disrupter" in travel. The company is expanding its presence in Egypt with two new Nile River ships, the Viking Ptah and Viking Sekhmet, now floated out. These developments highlight both external recognition of Viking's approach and concrete growth in its premium river cruise offering. For investors tracking NYSE:VIK, the TIME100 recognition arrives alongside a share price of $81.91 and a...
NYSE:ESI
NYSE:ESIChemicals

A Look At Element Solutions (ESI) Valuation After Record Q1 And Raised 2026 EBITDA Guidance

Element Solutions (ESI) opened 2026 with a record first quarter, combining strong electronics driven sales, contributions from Micromax and EFC, raised adjusted EBITDA guidance, and ongoing capacity and R&D spending despite softer GAAP net income. See our latest analysis for Element Solutions. The record Q1 update, raised adjusted EBITDA guidance, AI and data center exposure, and recent acquisitions have been met with strong market interest, with the share price at $42.59 and a 64.19% year to...
NYSE:BIO
NYSE:BIOLife Sciences

Bio-Rad Weighs 2026 Outlook As Middle East Headwinds Meet Stilla Hopes

Bio-Rad Laboratories (NYSE:BIO) issued a cautious revenue outlook for 2026. The company highlighted a material revenue impact tied to ongoing geopolitical disruptions in the Middle East. Management reported progress on the Stilla acquisition, which is expected to be accretive within the year, and outlined business efficiency measures. Bio-Rad enters this update with a mixed track record, with the share price at $280.12 and a 1 year return of 16.5% but a 3 year return of 39.4% and a 5 year...
NasdaqGS:EXLS
NasdaqGS:EXLSProfessional Services

A Look At ExlService Holdings (EXLS) Valuation As Investor Sentiment Shifts After Mixed Recent Returns

How ExlService Holdings’ Recent Performance Sets the Stage for Investors ExlService Holdings (EXLS) has drawn fresh investor attention after a mixed stretch in its share performance, with a modest gain over the past month contrasting with weaker returns over the past 3 months and year to date. See our latest analysis for ExlService Holdings. That recent 4.7% 30 day share price return comes after a much weaker 90 day share price return of 18.6% and a 1 year total shareholder return of 31.2%...
NYSE:VSCO
NYSE:VSCOSpecialty Retail

Does Wall Street’s Renewed Interest in Victoria’s Secret (VSCO) Change The Bull Case For Its Turnaround?

In recent days, Victoria’s Secret & Co. received an upgrade to Buy from Neutral by Bank of America and was highlighted as a key “under‑the‑radar” holding in David Einhorn’s portfolio, underscoring growing attention from both Wall Street and hedge fund investors. The company’s ability to gain market share in a contracting intimates market, tied to its Path to Potential turnaround strategy, is emerging as a central reason for this renewed interest. We’ll now examine how Bank of America’s...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

How Investors Are Reacting To Willdan Group (WLDN) Bullish Ratings Amid Risk of Earnings Shortfall

In recent days, Willdan Group drew investor attention as analysts projected higher year-over-year earnings and revenue for the March 2026 quarter while also flagging a negative Earnings ESP that points to a heightened risk of an earnings shortfall versus consensus expectations. At the same time, multiple research and data providers reinforced a Strong Buy analyst consensus on Willdan, underscoring a sharp contrast between bullish sentiment and lingering uncertainty around the upcoming...
NYSE:CBZ
NYSE:CBZProfessional Services

CBIZ (CBZ) Q1 Margin Strength Reinforces Bullish Profitability Narrative

CBIZ (CBZ) opened 2026 with Q1 revenue of US$848.6 million and basic EPS of US$2.63, alongside trailing 12 month revenue of about US$2.8 billion and EPS of US$2.48 that sit against a reported 77.5% earnings jump over the last year. The company has seen quarterly revenue move from US$838.0 million in Q1 2025 to US$848.6 million in Q1 2026, while basic EPS shifted from US$1.92 to US$2.63 over the same period. This sets up the latest release against a backdrop of 5.6% trailing net margins versus...
NasdaqGS:CPB
NasdaqGS:CPBFood

A Look At Campbell's (CPB) Valuation After Recent Share Price Reset

Event context and recent performance Campbell's (CPB) shares recently closed at $20.79, with returns of about 2% over the past day but negative moves over the past week, month and past 3 months drawing fresh attention to the stock. See our latest analysis for Campbell's. The recent 1 day share price return of 1.66% sits against a weaker backdrop, with a 30 day share price return of 6.65% and a 90 day share price return of 25.70%, while the 1 year total shareholder return of 38.67% and 5 year...
NYSE:ONTO
NYSE:ONTOSemiconductor

Is It Too Late To Consider Onto Innovation (ONTO) After Its Recent Share Price Surge?

If you are wondering whether Onto Innovation at around US$295 a share still makes sense for your portfolio, the next step is to separate price from underlying value. The stock has recorded returns of 0.9% over the last 7 days, 43.9% over 30 days, 77.9% year to date, 144.4% over 1 year, 259.3% over 3 years and 360.6% over 5 years, which naturally raises questions about what is already reflected in the current price. Recent coverage has focused on Onto Innovation as a key player within the...